• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鼻 CD103 树突状细胞中的 Toll 样受体 3 参与免疫球蛋白 A 的产生。

Toll-like receptor 3 in nasal CD103 dendritic cells is involved in immunoglobulin A production.

机构信息

Department of Microbiology and Immunology, Graduate School of Medicine, Hokkaido University, Sapporo, Japan.

Department of Immunology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.

出版信息

Mucosal Immunol. 2018 Jan;11(1):82-96. doi: 10.1038/mi.2017.48. Epub 2017 Jun 15.

DOI:10.1038/mi.2017.48
PMID:28612840
Abstract

Intranasal inoculation with influenza hemagglutinin subunit with polyinosine-polycytidylic (polyI:C), a synthetic analog for double-stranded RNA, enhances production of vaccine-specific immunoglobulin (Ig) A, which is superior to IgG in prophylactic immunity. The mechanism whereby polyI:C skews to IgA production in the nasal-associated lymph tissue (NALT) was investigated in mouse models. Nasally instilled polyI:C was endocytosed into CD103 dendritic cells (DCs) and induced T-cell activation, including interferon (IFN)-γ production. According to knockout mouse studies, polyI:C activated the Toll-like receptor 3 signal via the adapter TICAM-1 (also called TRIF), that mainly caused T-cell-dependent IgA production. Nasal CD103 DCs activated transforming growth factor-β signaling and activation-induced cytidine deaminase upon polyI:C stimulation. IgA rather than IgG production was impaired in Batf3 mice, where CD103 DCs are defective. Genomic recombination occurred in IgA-producing cells in association with polyI:C-stimulated DCs and nasal microenvironment. PolyI:C induced B-cell-activating factor expression and weakly triggered T-cell-independent IgA production. PolyI:C simultaneously activated mitochondrial antiviral signaling and then type I IFN receptor pathways, which only minimally participated in IgA production. Taken together, CD103 DCs in NALT are indispensable for the adjuvant activity of polyI:C in enhancing vaccine-specific IgA induction and protective immunity against influenza viruses.

摘要

鼻腔接种流感血凝素亚单位与聚肌苷酸-聚胞苷酸(polyI:C),一种双链 RNA 的合成类似物,可增强疫苗特异性免疫球蛋白(Ig)A 的产生,其在预防免疫中优于 IgG。本研究旨在探讨 polyI:C 在鼻相关淋巴组织(NALT)偏向 IgA 产生的机制。滴鼻给予的 polyI:C 被 CD103 树突状细胞(DCs)内吞,并诱导 T 细胞活化,包括干扰素(IFN)-γ的产生。根据敲除小鼠研究,polyI:C 通过衔接子 TICAM-1(也称为 TRIF)激活 Toll 样受体 3 信号,主要引起 T 细胞依赖性 IgA 产生。鼻 CD103 DCs 在 polyI:C 刺激下激活转化生长因子-β信号和激活诱导胞苷脱氨酶。Batf3 小鼠(CD103 DC 缺陷)中,polyI:C 诱导的 IgA 而非 IgG 产生受损。与 polyI:C 刺激的 DC 和鼻微环境相关,IgA 产生细胞发生了基因组重组。polyI:C 诱导 B 细胞激活因子的表达,并弱触发 T 细胞非依赖性 IgA 产生。polyI:C 同时激活线粒体抗病毒信号,然后是 I 型 IFN 受体途径,它们仅轻微参与 IgA 产生。综上所述,NALT 中的 CD103 DC 对于 polyI:C 增强疫苗特异性 IgA 诱导和抗流感病毒保护性免疫的佐剂活性是必不可少的。

相似文献

1
Toll-like receptor 3 in nasal CD103 dendritic cells is involved in immunoglobulin A production.鼻 CD103 树突状细胞中的 Toll 样受体 3 参与免疫球蛋白 A 的产生。
Mucosal Immunol. 2018 Jan;11(1):82-96. doi: 10.1038/mi.2017.48. Epub 2017 Jun 15.
2
Mesenteric CD103DCs Initiate Switched Coxsackievirus B3 VP1-Specific IgA Response to Intranasal Chitosan-DNA Vaccine Through Secreting BAFF/IL-6 and Promoting Th17/Tfh Differentiation.肠系膜 CD103DCs 通过分泌 BAFF/IL-6 和促进 Th17/Tfh 分化,启动鼻内壳聚糖-DNA 疫苗对柯萨奇病毒 B3 VP1 特异性 IgA 应答。
Front Immunol. 2018 Dec 18;9:2986. doi: 10.3389/fimmu.2018.02986. eCollection 2018.
3
Vaccine adjuvant ARNAX promotes mucosal IgA production in influenza HA vaccination.疫苗佐剂 ARNAX 促进流感血凝素疫苗接种中的黏膜 IgA 产生。
Biochem Biophys Res Commun. 2018 Dec 2;506(4):1019-1025. doi: 10.1016/j.bbrc.2018.10.166. Epub 2018 Nov 4.
4
Double-Stranded Structure of the Polyinosinic-Polycytidylic Acid Molecule to Elicit TLR3 Signaling and Adjuvant Activity in Murine Intranasal A(H1N1)pdm09 Influenza Vaccination.聚肌胞诱导 TLR3 信号和佐剂活性的双链结构及其在鼠鼻腔接种 A(H1N1)pdm09 流感疫苗中的作用。
DNA Cell Biol. 2020 Sep;39(9):1730-1740. doi: 10.1089/dna.2019.5324. Epub 2020 Jun 22.
5
Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands Work Additively via MyD88 To Induce Protective Antiviral Immunity in Mice.合成的Toll样受体4(TLR4)和TLR7配体通过髓样分化因子88(MyD88)协同作用,在小鼠中诱导保护性抗病毒免疫。
J Virol. 2017 Sep 12;91(19). doi: 10.1128/JVI.01050-17. Print 2017 Oct 1.
6
Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection.合成双链RNA聚肌苷酸胞嘧啶核苷酸(poly(I:C))与黏膜疫苗联合使用可预防流感病毒感染。
J Virol. 2005 Mar;79(5):2910-9. doi: 10.1128/JVI.79.5.2910-2919.2005.
7
Intranasal administration of adjuvant-combined recombinant influenza virus HA vaccine protects mice from the lethal H5N1 virus infection.经鼻内给予佐剂联合重组流感病毒HA疫苗可保护小鼠免受致死性H5N1病毒感染。
Microbes Infect. 2006 Oct;8(12-13):2706-14. doi: 10.1016/j.micinf.2006.07.018. Epub 2006 Aug 28.
8
Colonization-induced protection against invasive pneumococcal disease in mice is independent of CD103 driven adaptive immune responses.定植诱导的对侵袭性肺炎球菌病的保护作用与 CD103 驱动的适应性免疫反应无关。
Eur J Immunol. 2018 Jun;48(6):965-974. doi: 10.1002/eji.201747236. Epub 2018 Apr 11.
9
Peripheral CD103+ dendritic cells form a unified subset developmentally related to CD8alpha+ conventional dendritic cells.外周血 CD103+树突状细胞形成一个统一的亚群,在发育上与 CD8α+传统树突状细胞相关。
J Exp Med. 2010 Apr 12;207(4):823-36. doi: 10.1084/jem.20091627. Epub 2010 Mar 29.
10
Intranasal delivery of a cDC1 targeted influenza vaccine with poly(I:C) enhances T cell responses and protects against influenza infection.鼻内递送靶向树突状细胞的流感疫苗与聚肌苷酸:胞苷酸增强 T 细胞反应并预防流感感染。
Scand J Immunol. 2022 Mar;95(3):e13128. doi: 10.1111/sji.13128. Epub 2021 Dec 27.

引用本文的文献

1
ARNAX is an ideal adjuvant for COVID-19 vaccines to enhance antigen-specific CD4 and CD8 T-cell responses and neutralizing antibody induction.ARNAX是新冠疫苗增强抗原特异性CD4和CD8 T细胞反应以及诱导中和抗体的理想佐剂。
J Virol. 2025 May 20;99(5):e0229024. doi: 10.1128/jvi.02290-24. Epub 2025 Apr 15.
2
Harnessing the potential of the NALT and BALT as targets for immunomodulation using engineering strategies to enhance mucosal uptake.利用 NALT 和 BALT 的潜力,通过工程策略作为免疫调节的靶点,以增强黏膜摄取。
Front Immunol. 2024 Sep 2;15:1419527. doi: 10.3389/fimmu.2024.1419527. eCollection 2024.
3
Evaluation of the TLR3 involvement during Schistosoma japonicum-induced pathology.

本文引用的文献

1
Microbiota regulate the ability of lung dendritic cells to induce IgA class-switch recombination and generate protective gastrointestinal immune responses.微生物群调节肺树突状细胞诱导IgA类别转换重组并产生保护性胃肠道免疫反应的能力。
J Exp Med. 2016 Jan 11;213(1):53-73. doi: 10.1084/jem.20150567. Epub 2015 Dec 28.
2
PU.1 Expression in T Follicular Helper Cells Limits CD40L-Dependent Germinal Center B Cell Development.PU.1在滤泡辅助性T细胞中的表达限制了CD40L依赖性生发中心B细胞的发育。
J Immunol. 2015 Oct 15;195(8):3705-15. doi: 10.4049/jimmunol.1500780. Epub 2015 Sep 11.
3
Influenza vaccines: challenges and solutions.
评估 TLR3 在日本血吸虫病发病机制中的作用。
BMC Immunol. 2024 Jan 3;25(1):2. doi: 10.1186/s12865-023-00586-9.
4
Two Modes of Th1 Polarization Induced by Dendritic-Cell-Priming Adjuvant in Vaccination.两种树突状细胞疫苗佐剂诱导的 Th1 极化模式。
Cells. 2023 May 29;12(11):1504. doi: 10.3390/cells12111504.
5
Establishment of isotype-switched, antigen-specific B cells in multiple mucosal tissues using non-mucosal immunization.利用非黏膜免疫在多个黏膜组织中建立同种型转换的、抗原特异性B细胞。
NPJ Vaccines. 2023 May 31;8(1):80. doi: 10.1038/s41541-023-00677-z.
6
The Respiratory Commensal Bacterium as a Mucosal Adjuvant for Nasal Vaccines.呼吸道共生细菌作为鼻用疫苗的黏膜佐剂
Vaccines (Basel). 2023 Mar 8;11(3):611. doi: 10.3390/vaccines11030611.
7
Novel intranasal vaccine targeting SARS-CoV-2 receptor binding domain to mucosal microfold cells and adjuvanted with TLR3 agonist Riboxxim™ elicits strong antibody and T-cell responses in mice.新型靶向 SARS-CoV-2 受体结合域的鼻腔内疫苗,佐以 TLR3 激动剂 Riboxxim™,可在小鼠中引发强烈的抗体和 T 细胞反应。
Sci Rep. 2023 Mar 21;13(1):4648. doi: 10.1038/s41598-023-31198-3.
8
Toward Establishing an Ideal Adjuvant for Non-Inflammatory Immune Enhancement.为非炎症性免疫增强建立理想佐剂。
Cells. 2022 Dec 11;11(24):4006. doi: 10.3390/cells11244006.
9
Mucosal delivery of nanovaccine strategy against COVID-19 and its variants.针对新冠病毒及其变体的纳米疫苗黏膜给药策略
Acta Pharm Sin B. 2022 Nov 21;13(7):2897-925. doi: 10.1016/j.apsb.2022.11.022.
10
Towards the future exploration of mucosal mRNA vaccines against emerging viral diseases; lessons from existing next-generation mucosal vaccine strategies.迈向针对新出现病毒性疾病的黏膜mRNA疫苗的未来探索;现有下一代黏膜疫苗策略的经验教训。
NPJ Vaccines. 2022 Jun 28;7(1):71. doi: 10.1038/s41541-022-00485-x.
流感疫苗:挑战与解决方案。
Cell Host Microbe. 2015 Mar 11;17(3):295-300. doi: 10.1016/j.chom.2015.02.012.
4
Defined TLR3-specific adjuvant that induces NK and CTL activation without significant cytokine production in vivo.定义 TLR3 特异性佐剂,可在体内诱导 NK 和 CTL 激活而不产生显著细胞因子。
Nat Commun. 2015 Feb 18;6:6280. doi: 10.1038/ncomms7280.
5
Intranasal administration of TLR agonists induces a discriminated local innate response along murine respiratory tract.经鼻内给予Toll样受体(TLR)激动剂可诱导小鼠呼吸道产生有区别的局部固有免疫反应。
Immunol Lett. 2015 Mar;164(1):33-9. doi: 10.1016/j.imlet.2015.01.004. Epub 2015 Jan 28.
6
Influenza promotes collagen deposition via αvβ6 integrin-mediated transforming growth factor β activation.流感通过αvβ6整合素介导的转化生长因子β激活促进胶原蛋白沉积。
J Biol Chem. 2014 Dec 19;289(51):35246-63. doi: 10.1074/jbc.M114.582262. Epub 2014 Oct 22.
7
Dendritic cell subsets involved in type I IFN induction in mouse measles virus infection models.参与小鼠麻疹病毒感染模型中I型干扰素诱导的树突状细胞亚群。
Int J Biochem Cell Biol. 2014 Aug;53:329-33. doi: 10.1016/j.biocel.2014.05.001. Epub 2014 Jun 4.
8
Interleukin-21: a double-edged sword with therapeutic potential.白细胞介素-21:一把具有治疗潜力的双刃剑。
Nat Rev Drug Discov. 2014 May;13(5):379-95. doi: 10.1038/nrd4296. Epub 2014 Apr 22.
9
MAVS-dependent IRF3/7 bypass of interferon β-induction restricts the response to measles infection in CD150Tg mouse bone marrow-derived dendritic cells.MAVS 依赖性 IRF3/7 绕过干扰素 β 诱导,限制了 CD150Tg 鼠骨髓来源树突状细胞对麻疹感染的反应。
Mol Immunol. 2014 Feb;57(2):100-10. doi: 10.1016/j.molimm.2013.08.007. Epub 2013 Oct 4.
10
The MyD88 pathway in plasmacytoid and CD4+ dendritic cells primarily triggers type I IFN production against measles virus in a mouse infection model.浆细胞样树突状细胞和 CD4+树突状细胞中的 MyD88 通路主要在小鼠感染模型中针对麻疹病毒引发 I 型 IFN 的产生。
J Immunol. 2013 Nov 1;191(9):4740-7. doi: 10.4049/jimmunol.1301744. Epub 2013 Sep 27.